Why Verify Med Codes is The Chosen AI Coding Standard
Major "Competitors" Have Raised Hundreds of Millions of Dollars:
VerifyMedCodes.ai is Worth Hundreds of Millions, but Doesn't Need Hundreds of Millions.
It's Validated and Commercially Viable.
Abridge
Raised $300 million in a Series E round in June 2025, led by Andreessen Horowitz, at a valuation of approximately $5.3 billion TechCrunchReutersThe Wall Street Journal.
This latest funding closely followed a $250 million raise in February 2025, raising its prior valuation from around $850 million ReutersThe Wall Street Journal.
Abridge specializes in AI that listens to doctor–patient conversations, transcribing and documenting medical notes, and integrating billing code validation The Wall Street Journal.
Abridge data can be fed into VerifyMedCode.ai and we do the rest, full lifecycle, even through audits and denial appeals.
Ambience Healthcare
Raised $243 million in a Series C round in August 2025, co-led by Oak HC/FT and Andreessen Horowitz (a16z), with backing from partners including OpenAI Startup Fund and Kleiner Perkins Business Insider.
Their platform delivers ambient transcription of doctor–patient interactions and automates administrative functions such as medical coding and payment processing Business Insider.
OpenEvidence
Secured a $75 million Series A in February 2025, followed by a massive $210 million Series B in July 2025, bringing total funding to over $300 million and a valuation of ~$3.5 billion Wikipedia.
Although not strictly focused on medical coding, OpenEvidence provides a powerful AI search platform for physicians—leveraging peer-reviewed medical literature for real-time clinical decision support Wikipedia.
OpenEvidence does not come close to VerifyMedCodes.ai in all of its capabilities, and VerifyMedCodes.ai specializes in Medical Coding, as well as real-time, AI-assisted medical decision making, differentials, and future recommendations for the patient experience. VerifyMedCodes.ai would replace any need for OpenEvidence.
Other Notable Players (Lower Fundings)
Arintra
Raised $21 million in Series A (August 2025) for AI-driven autonomous medical coding tools—which is not in the “hundreds of millions” range arintra.comMedCity NewsThe Economic Times.
Arintra does not have dictation capabilities, and it's not pro-actively intelligent. It's more narrow and a risk assessment tool. VerifyMedCodes.ai would replace the need for Arintra as well, and do so much more.
Navina
Raised $55 million in Series C (March 2025), bringing total funding to $100 million. Not in the hundreds-of-millions tier Business Insider.
Heidi Health (Australia)
Raised about USD 26 million total (March 2025), focused on AI medical scribing; still below the threshold Wikipedia.
🗹 What systems out there bring benefits immediately?
Verify Med Codes was co-founded and designed by one of the top Epic Integrators in the country, a progressive healthcare administrator, and a few frustrated physicians. They have integrated systems with every tool in the book, and they have used almost every major system available in the marketplace.
Our Motto: To always optimize revenue cycles, workflows, and create audit-proof RVUs.
Bring immediate relief, only joy, and to design a system that is ridiculously easy to use.
VerifyMedCodes.ai is made to be so intuitive, someone can sit down with no training whatsoever, and just start using it. This ai-tool is not only the most robust on the market, it's also the fastest most thorough, easiest and most intuitive ai-assisted coding and medical guidance success software system in the market.
Also committed to staying reasonably priced, and to bring as immediate ROI as possible.
ROI begins with the first note, and never ends. The system keeps getting smarter and smarter.
Patients win with better coverage, more attention, more thorough care, and improved health.
Verify Med Codes can even help discover diagnoses that could otherwise have been overlooked.
Everyone wins, and fast.
🗹 What systems out there don't require any support?
🎗While VerifyMedCodes offers incredible support, you won't need it.
The system just works, and gets better and better every day.
We partner with our users in a way that gives you a voice to influence what we develop next!
🗹 What system out there optimizes RVUs and RCMs better?
None. Nothing comes close to how thorough, reliable, intuitive, fast, and insightful/useful it is.
Nothing comes close to how cost-effective our operations and our technology is either.
We Cracked the Code.
Market Overview – U.S. Medical Coding (Revenue)
U.S. medical coding market (software + services): $21.9B (2024); forecast $24.0B (2025); ~10% CAGR through 2033. Grand View Research
Other forecasts align closely—NovaOne projects USD 19.2 billion in 2023, growing to USD 49.17 billion by 2033 (CAGR ~9.86%) Nova One Advisor.
Bottom Line: The U.S. medical coding revenue base ranges between USD 20–22 billion today and is expected to double by the early 2030s, driven by digitization, increased coding complexity, and greater billing accuracy needs.
Volume – U.S. Clinical Notes Processed Annually
2024 Studies for the U.S.:
CDC FastStats lists ~1.0B physician office visits/year (latest CDC FastStats page; summary tables reference NAMCS). That’s ~2.74M/day and ~82M per 30-day month. CDC
Estimation for U.S. Scale:
If that health system represented, say, 0.1% of national volume (purely illustrative), annual note creation could approximate 17 million ÷ 0.001 = 17 billion notes per year. (Exact national figures are not publicly available, but billions of clinical notes annually is a reasonable assumption.)
AI Spend – U.S. Spending for AI-Assisted Medical Coding
2024 U.S. Annual Volume of Progress Notes:
Physician Office Visits: ~1 billion notes/year
Hospital Outpatient, Inpatient Admissions, & ED:
Another ~1 billion notes/year
Other Providers (NP, PAs, PT/OT, SNFs, Hospice):
High hundreds of millions or ~1 billion notes/year
Computer-Assisted Coding (CAC)/AI coding (global) market: ~$5.66B (2024); U.S. typically represents a large share of health IT spend. Mordor Intelligence
Regionally, the U.S. AI in medical coding market is forecast at:
USD $590 million in 2024
Reaching USD $2.07 billion by 2034 (CAGR ~13.4%) Precedence Research.
In addition to this, there are multipliers and adjacencies that VerifyMedCodes.ai addresses.
AI-Assisted Coding TAM
& Second Order Value Drivers
MetricValue / Forecast
U.S. medical coding market (revenue)~$21.9 B in 2024 → ~$44 B by 2032 (CAGR ~9.4%)
Notes processed annually (est.)Billions per year ~17 M in one system; national scale implies billions
U.S. AI in medical coding spend
~$590M in 2024 → ~$2.07 B by 2034 (CAGR ~13.4%)
Global AI coding market
~$2.4 B in 2023 → ~$7.4B by 2032 (CAGR ~13.6%)
Core TAM (Medical Coding): $22B → $44B by 2032
AI Wedge TAM: $590M → $2.1B by 2034
Expandable TAM (adjacencies):
Denials & Audit Costs: $250B+
Provider Productivity: $10–30B equivalent
Misdiagnosis/Patient Safety Costs: $10–20B
Reimbursement Leakage: $100B+
No Matter How You Slice it, It's Mind-Blowing.
We Have the Dream Solution.
VerifyMedCodes.ai not just a coding tool, but also a healthcare financial and compliance optimization tool, and a systems integration partner,
👉which multiplies the TAM from tens of billions → hundreds of billions in potential impact.
As rules and procedures keep changing, and opportunities keep arising, we rise to the challenge, and thrill.
Call or Text National Headquarters: 602-500-0229
Call or Text Eastern Region: 570-605-4700
